Home > SOP Information > SOPs and Supporting Information – alphabetic listing > N to P > Psoriasis M009 > Rulebase for psoriasis > Treatment with a specified drug

Treatment with a specified drug

Psoriasis - Treatment with a specified drug Factor

Last reviewed for CCPS 10 June 2012.

Investigative Documents

Medical Report - Drug Treatment as a cause of Psoriasis [MR9152]

Preliminary questions [25209]

[1]25210

there is some evidence that treatment with a drug from the specified list for psoriasis may be a factor in the development or worsening of the condition under consideration.

25211 [2] the veteran has been treated with a drug from the specified list for psoriasis at some time.

[3]25212

the veteran was treated with a drug from the specified list for psoriasis for an illness or injury which is identifiable.

15035 — the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and VEA service for psoriasis.

[4]32371

the veteran was undergoing treatment for the identified illness or injury with a drug from the specified list for psoriasis at the time of the clinical onset of psoriasis.

15036 — the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and VEA service for the clinical onset of psoriasis.

15038 — the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and operational service for the clinical onset of psoriasis.

or

15039 — the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and eligible service for the clinical onset of psoriasis.

or

[5]7334

the clinical onset of the condition under consideration occurred after the end of the veteran's last period of VEA service.

[6]7335

the condition under consideration permanently worsened.

[7]25213

the veteran was undergoing treatment for the identified illness or injury with a drug from the specified list for psoriasis at the time of the clinical worsening of psoriasis.

15037 — the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and VEA service for the clinical worsening of psoriasis.

15040 — the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and operational service for the clinical worsening of psoriasis.

or

15041 — the veteran has established the causal connection between the treatment with a drug from the specified list for psoriasis and eligible service for the clinical worsening of psoriasis.

Clinical onset and operational service [15038]

25217 — the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to operational service. [8] [9]

Clinical onset and eligible service [15039]

25219 — the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to eligible service. [10] [9]

Clinical worsening and operational service [15040]

25217 — the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to operational service. [11] [9]

[12]25218

the clinical onset of psoriasis occurred prior to that part of operational service to which the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related.

Clinical worsening and eligible service [15041]

25219 — the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related to eligible service. [13] [9]

[14]25220

the clinical onset of psoriasis occurred prior to that part of eligible service to which the identified illness or injury, for which treatment with a drug from the specified list for psoriasis was given, is causally related. [15]

Source URL (modified on 20/10/2014 - 3:25pm): https://clik.dva.gov.au/ccps-medical-research-library/statements-principles/n-p/psoriasis-m009-l400l401l402l40/rulebase-psoriasis/treatment-specified-drug

Links
[1] https://clik.dva.gov.au/ccpsmedical-150
[2] https://clik.dva.gov.au/ccpsm009rc-8
[3] clikpopup://CCPS/reject25211No
[4] clikpopup://CCPS/reject25212No
[5] clikpopup://CCPS/reject32371No
[6] clikpopup://CCPS/Reject/OnsetAfterService
[7] clikpopup://CCPS/Reject/NoPermanentWorsening
[8] clikpopup://CCPS/reject25213No
[9] clikpopup://CCPS/reject25217,25219No
[10] clikpopup://CCPS/reject25219No
[11] clikpopup://CCPS/reject25217No
[12] clikpopup://CCPS/Onset of psoriasis prior to op service which ill/inj treated with a drug is causally related
[13] clikpopup://CCPS/reject25218No
[14] clikpopup://CCPS/Onset of psoriasis prior to el service which ill/inj treated with a drug is causally related
[15] clikpopup://CCPS/reject25220No